Douglas Dynamics (NYSE:PLOW) Q4 2025 Earnings call February 24, 2026 10:00 AM ET Company ParticipantsMark Van Genderen - President and CEONathan Elwell - VP of Investor RelationsSarah Lauber - EVP and CFOConference Call ParticipantsGreg Burns - Senior AnalystMichael Shlisky - Managing Director and Senior Equity Research AnalystTimothy Wojs - Senior Research AnalystOperatorPlease note, this event is being recorded. I would now like to turn the conference over to Nathan Elwell, Vice President, Investor Relati ...

Group 1 - The core viewpoint of the article highlights that Haijia Medical (06078) has seen a stock price increase of over 4%, currently trading at 12.6 HKD with a transaction volume of 40.78 million HKD [1] - Haijia Medical announced a share buyback of approximately 6.0098 million HKD for 493,800 shares on December 17 [1] - The company plans to utilize its buyback authorization to repurchase shares in the open market for a total price of no less than 300 million RMB [1] Group 2 - According to CMB International, the pressure on cost control is easing, and the elimination of outdated production capacity is expected to allow private medical institutions to return to a faster growth trajectory [1] - CMB International recommends high-quality stocks like Haijia Medical, which are expected to see a rebound in short-term performance and have a clear long-term expansion path [1]